Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Clinical trial NCT00363727 · COMPLETED

Trial details

NCT number: NCT00363727
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease Parkinson Disease Dyskinesias

Start date: 2003-12-01
Primary completion: 2006-01-01
Enrollment: 209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.